Why is Venmax Drugs falling/rising?

As of 03-Nov, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 28.70, reflecting a change of 0.7 or 2.5% upward. The stock has shown strong performance recently, gaining 10.09% over the last three days and outperforming its sector by 1.2% today. Additionally, over the past month, the stock has surged by 42.43%, significantly outpacing the Sensex, which has only increased by 3.41%. However, it is important to note that there has been a notable decline in investor participation, with delivery volume dropping by 77.96% against the five-day average, which may indicate a potential concern regarding sustained interest in the stock.
In the broader market context, Venmax Drugs has outperformed the Sensex over the past week, with a return of 1.59% compared to the benchmark's decline of 0.94%. Year-to-date, the stock has also significantly outperformed the Sensex, achieving a return of 59.09% against the benchmark's 7.47%. This strong performance amidst a generally weaker market suggests that investor sentiment towards Venmax Drugs remains positive, despite the recent drop in delivery volume. The stock's consistent trading above its moving averages further supports its upward trajectory, indicating a bullish trend in the short term.